PMG
AMED

ProVise Management Group’s Amedisys AMED Stock Holding History

ProVise Management Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,653
Closed -$438K – 386
2021
Q1 		$438K Hold
1,653
– – 0.05% 231
2020
Q4 		$485K Sell
1,653
-16
-1% -$4.1K 0.06% 211
2020
Q3 		$395K Buy
+1,669
New +$379K 0.05% 211

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ProVise Management Group's AMED Position: Q2 2021 in Review

ProVise Management Group sold out of Amedisys (AMED) in Q2 2021, closing a stake of 1,653 shares — an estimated $438K sold.

ProVise Management Group first reported a position in AMED in Q3 2020 and held it in 3 quarters. The position peaked at $485K in Q4 2020. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • ProVise Management Group reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • ProVise Management Group sold 1,653 Amedisys shares in Q2 2021, an estimated $438K.
  • ProVise Management Group first reported a position in Amedisys in Q3 2020 and held it in 3 quarters.
  • ProVise Management Group's Amedisys position peaked at $485K in Q4 2020.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on ProVise Management Group's 13F filing for Q2 2021, filed 6 Aug 2021.